Summary
For Year 2026-27, Bharat Parenterals reports the following shareholding: Total Promoters at 67.17%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.11%, Domestic Institutional Investors at 1.06%, and Retail at 31.66%. This breakdown provides a quick snapshot of ownership distribution for Bharat Parenterals in 2026-27.
Bharat Parenterals FAQs
As of 04-2026, the promoter shareholding in Bharat Parenterals stands at 67.17% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Bharat Parenterals is 0.11% and 1.06% respectively.
The retail shareholding of the Bharat Parenterals is 31.66%.
Changes in shareholding patterns of Bharat Parenterals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Bharat Parenterals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Bharat Parenterals Associated Pages
